Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 959

1.

Treatment and Long-Term Outcomes of Primary Central Nervous System Vasculitis: Updated Results From the French Registry.

de Boysson H, Arquizan C, Touzé E, Zuber M, Boulouis G, Naggara O, Guillevin L, Aouba A, Pagnoux C.

Stroke. 2018 Jul 9. pii: STROKEAHA.118.021878. doi: 10.1161/STROKEAHA.118.021878. [Epub ahead of print]

PMID:
29986936
2.

Response to: 'Not all drugs (and routes) are same' by Zanwar and Gandhi.

Charles P, Guillevin L.

Ann Rheum Dis. 2018 Jun 1. pii: annrheumdis-2018-213742. doi: 10.1136/annrheumdis-2018-213742. [Epub ahead of print] No abstract available.

PMID:
29858174
3.

Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.

Raffray L, Guillevin L.

Drugs. 2018 May 15. doi: 10.1007/s40265-018-0920-8. [Epub ahead of print]

PMID:
29766394
4.

Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry.

Jardel S, Puéchal X, Le Quellec A, Pagnoux C, Hamidou M, Maurier F, Aumaitre O, Aouba A, Quemeneur T, Subra JF, Cottin V, Sibilia J, Godmer P, Cacoub P, Fauchais AL, Hachulla E, Maucort-Boulch D, Guillevin L, Lega JC; French Vasculitis Study Group (FVSG).

Autoimmun Rev. 2018 Jul;17(7):653-659. doi: 10.1016/j.autrev.2018.01.022. Epub 2018 May 3. Review.

PMID:
29730524
5.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
6.

Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.

Puéchal X, Iudici M, Calich AL, Vivot A, Terrier B, Régent A, Cohen P, Jeunne CL, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Rheumatology (Oxford). 2018 May 2. doi: 10.1093/rheumatology/key117. [Epub ahead of print]

PMID:
29722877
7.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25.

PMID:
29695500
8.

Maintenance of Remission in antineutrophil cytoplasm antibody-associated vasculitides.

Guillevin L, Terrier B.

Int J Rheum Dis. 2018 Apr 19. doi: 10.1111/1756-185X.13303. [Epub ahead of print] No abstract available.

PMID:
29673090
9.

Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need?

Mavrogeni S, Kitas GD, Lamb HJ, Psychoyios K, Dimitroulas T, Koutsogeorgopoulou L, Boki K, Vartela V, Kolovou G, Markousis-Mavrogenis G, Kallenberg CG, Guillevin L, Vassilopoulos D.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):152-159. Epub 2018 Apr 10. Review.

10.

mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G.

Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group.

Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017.

PMID:
29506143
11.

[Editorial orientations for La Presse Médicale].

Guillevin L; pour le Comité de rédaction.

Presse Med. 2018 Jan;47(1):1-2. doi: 10.1016/j.lpm.2018.02.003. French. No abstract available.

PMID:
29502586
12.

Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry.

Iudici M, Pagnoux C, Quartier P, Büchler M, Cevallos R, Cohen P, de Moreuil C, Guilpain P, Le Quellec A, Serratrice J, Terrier B, Guillevin L, Mouthon L, Puéchal X; French Vasculitis Study Group.

Autoimmun Rev. 2018 Feb;17(2):108-114. doi: 10.1016/j.autrev.2017.11.014. Epub 2017 Nov 24. Review.

PMID:
29180123
13.

Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.

de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA.

Rheumatology (Oxford). 2017 Nov 1;56(11):1894-1901. doi: 10.1093/rheumatology/kex281.

PMID:
28977502
14.

Reply.

Puéchal X, Pagnoux C, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2018 Jan;70(1):151-152. doi: 10.1002/art.40334. Epub 2017 Nov 28. No abstract available.

PMID:
28950436
15.

Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides.

Frumholtz L, Laurent-Roussel S, Aumaître O, Maurier F, Le Guenno G, Carlotti A, Dallot A, Kemeny JL, Antunes L, Froment N, Fraitag S, London J, Berezne A, Terris B, Le Jeunne C, Mouthon L, Aractingi S, Guillevin L, Dupin N, Terrier B; French Vasculitis Study Group.

Autoimmun Rev. 2017 Nov;16(11):1138-1146. doi: 10.1016/j.autrev.2017.09.009. Epub 2017 Sep 14. Review.

PMID:
28918161
16.

Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, Hellmich B, Jayne D, Jennette JC, Kallenberg CGM, Moiseev S, Novikov P, Radice A, Savige JA, Sinico RA, Specks U, van Paassen P, Zhao MH, Rasmussen N, Damoiseaux J, Csernok E.

Nat Rev Rheumatol. 2017 Nov;13(11):683-692. doi: 10.1038/nrrheum.2017.140. Epub 2017 Sep 14. Review.

PMID:
28905856
17.

Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study.

Grabar S, Groh M, Bahuaud M, Le Guern V, Costedoat-Chalumeau N, Mathian A, Hanslik T, Guillevin L, Batteux F, Launay O; VACCILUP study group.

Vaccine. 2017 Sep 5;35(37):4877-4885. doi: 10.1016/j.vaccine.2017.07.094. Epub 2017 Aug 4.

PMID:
28784280
18.

Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome.

Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B; French Vasculitis Study Group.

Autoimmun Rev. 2017 Oct;16(10):1036-1043. doi: 10.1016/j.autrev.2017.07.020. Epub 2017 Aug 2. Review.

PMID:
28780079
19.

Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis.

Guillevin L.

Nat Rev Rheumatol. 2017 Sep;13(9):518-519. doi: 10.1038/nrrheum.2017.117. Epub 2017 Aug 3. No abstract available.

PMID:
28769112
20.

Concordance of Time-of-Flight MRA and Digital Subtraction Angiography in Adult Primary Central Nervous System Vasculitis.

de Boysson H, Boulouis G, Parienti JJ, Touzé E, Zuber M, Arquizan C, Dequatre N, Detante O, Bienvenu B, Aouba A, Guillevin L, Pagnoux C, Naggara O.

AJNR Am J Neuroradiol. 2017 Oct;38(10):1917-1922. doi: 10.3174/ajnr.A5300. Epub 2017 Jul 27.

PMID:
28751515
21.

Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature.

André R, Cottin V, Saraux JL, Blaison G, Bienvenu B, Cathebras P, Dhote R, Foucher A, Gil H, Lapoirie J, Launay D, Loustau V, Maurier F, Pertuiset E, Zénone T, Seebach J, Costedoat-Chalumeau N, Puéchal X, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG).

Autoimmun Rev. 2017 Sep;16(9):963-969. doi: 10.1016/j.autrev.2017.07.007. Epub 2017 Jul 12. Review.

PMID:
28709761
22.

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.

Puéchal X, Pagnoux C, Baron G, Quémeneur T, Néel A, Agard C, Lifermann F, Liozon E, Ruivard M, Godmer P, Limal N, Mékinian A, Papo T, Ruppert AM, Bourgarit A, Bienvenu B, Geffray L, Saraux JL, Diot E, Crestani B, Delbrel X, Sailler L, Cohen P, Le Guern V, Terrier B, Groh M, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Nov;69(11):2175-2186. doi: 10.1002/art.40205. Epub 2017 Oct 15.

PMID:
28678392
23.

Vasculitis for the internist: focus on ANCA-associated vasculitis.

Chaigne B, Guillevin L.

Intern Emerg Med. 2017 Aug;12(5):577-585. doi: 10.1007/s11739-017-1683-z. Epub 2017 Jun 16. Review.

PMID:
28623488
24.

Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey.

Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, Cacoub P, Jourde-Chiche N, Urbanski G, Augusto JF, Moulis G, Raffray L, Deroux A, Hummel A, Lioger B, Catroux M, Faguer S, Goutte J, Martis N, Maurier F, Rivière E, Sanges S, Baldolli A, Costedoat-Chalumeau N, Roriz M, Puéchal X, André M, Lavigne C, Bienvenu B, Mekinian A, Zagdoun E, Girard C, Bérezné A, Guillevin L, Thervet E, Pillebout E; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Sep;69(9):1862-1870. doi: 10.1002/art.40178.

PMID:
28605168
25.

Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

Karras A, Pagnoux C, Haubitz M, Groot K, Puechal X, Tervaert JWC, Segelmark M, Guillevin L, Jayne D; European Vasculitis Society.

Ann Rheum Dis. 2017 Oct;76(10):1662-1668. doi: 10.1136/annrheumdis-2017-211123. Epub 2017 May 25.

PMID:
28546260
26.

Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort).

Duquenne C, Wendling D, Sibilia J, Job-Deslandre C, Guillevin L, Benichou J, Flipo RM, Guillemin F, Saraux A.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):638-646. Epub 2017 May 15.

PMID:
28516872
27.

Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.

Samson M, Puéchal X, Mouthon L, Devilliers H, Cohen P, Bienvenu B, Ly KH, Bruet A, Gilson B, Ruivard M, Pertuiset E, Hamidou M, Pagnoux C, Terrier B, Guillevin L; French Vasculitis Study Group (FVSG).

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):176-184. Epub 2017 Apr 18.

28.

Maintenance treatment of ANCA-associated vasculitides.

Guillevin L.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):199-201. Epub 2017 Apr 5. Review.

PMID:
28406765
29.

Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study.

Demiselle J, Auchabie J, Beloncle F, Gatault P, Grangé S, Du Cheyron D, Dellamonica J, Boyer S, Beauport DT, Piquilloud L, Letheulle J, Guitton C, Chudeau N, Geri G, Fourrier F, Robert R, Guérot E, Boisramé-Helms J, Galichon P, Dequin PF, Lautrette A, Bollaert PE, Meziani F, Guillevin L, Lerolle N, Augusto JF.

Ann Intensive Care. 2017 Dec;7(1):39. doi: 10.1186/s13613-017-0262-9. Epub 2017 Apr 5.

30.

Maintenance therapy is associated with better long-term outcomes in adult patients with primary angiitis of the central nervous system.

de Boysson H, Parienti JJ, Arquizan C, Boulouis G, Gaillard N, Régent A, Néel A, Detante O, Touzé E, Aouba A, Bienvenu B, Guillevin L, Naggara O, Zuber M, Pagnoux C.

Rheumatology (Oxford). 2017 Oct 1;56(10):1684-1693. doi: 10.1093/rheumatology/kex047.

PMID:
28340158
31.

Cardiac involvement in granulomatosis with polyangiitis: a magnetic resonance imaging study of 31 consecutive patients.

Pugnet G, Gouya H, Puéchal X, Terrier B, Kahan A, Legmann P, Guillevin L, Vignaux O; French Vasculitis Study Group.

Rheumatology (Oxford). 2017 Jun 1;56(6):947-956. doi: 10.1093/rheumatology/kew490.

PMID:
28339663
32.

Primary Angiitis of the Central Nervous System: Magnetic Resonance Imaging Spectrum of Parenchymal, Meningeal, and Vascular Lesions at Baseline.

Boulouis G, de Boysson H, Zuber M, Guillevin L, Meary E, Costalat V, Pagnoux C, Naggara O; French Vasculitis Group.

Stroke. 2017 May;48(5):1248-1255. doi: 10.1161/STROKEAHA.116.016194. Epub 2017 Mar 22.

33.

Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation.

Régent A, Ly KH, Groh M, Khifer C, Lofek S, Clary G, Chafey P, Baud V, Broussard C, Federici C, Labrousse F, Mesturoux L, Le Jeunne C, Vidal E, Brezin A, Witko-Sarsat V, Guillevin L, Mouthon L.

Autoimmun Rev. 2017 Apr;16(4):398-406. doi: 10.1016/j.autrev.2017.02.006. Epub 2017 Feb 14. Review.

PMID:
28232168
34.

Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study.

Benarous L, Terrier B, Laborde-Casterot H, Bérezné A, Dunogué B, Cohen P, Puéchal X, Mouthon L, Bensefa-Colas L, Guillevin L; French Vasculitis Study Group (FVSG).

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):40-46. Epub 2016 Dec 20.

35.

Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population.

Terrier B, Dechartres A, Deligny C, Godmer P, Charles P, Hayem G, Dunogué B, de Bandt M, Cohen P, Puéchal X, Jeunne CL, Arfi S, Mouthon L, Guillevin L.

Rheumatology (Oxford). 2017 Mar 1;56(3):445-450. doi: 10.1093/rheumatology/kew423.

PMID:
27940591
36.

Adult primary angiitis of the central nervous system: isolated small-vessel vasculitis represents distinct disease pattern.

de Boysson H, Boulouis G, Aouba A, Bienvenu B, Guillevin L, Zuber M, Touzé E, Naggara O, Pagnoux C.

Rheumatology (Oxford). 2017 Mar 1;56(3):439-444. doi: 10.1093/rheumatology/kew434.

PMID:
27940585
37.

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault A, Jayne D, Guillevin L, Cordier JF; the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P).

Eur Respir J. 2016 Nov;48(5):1429-1441. doi: 10.1183/13993003.00097-2016. Epub 2016 Sep 1.

38.

Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault C, Pagnoux C, Jayne D, Guillevin L, Cordier JF; Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P).

Autoimmun Rev. 2017 Jan;16(1):1-9. doi: 10.1016/j.autrev.2016.09.018. Epub 2016 Sep 23.

PMID:
27671089
39.

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis.

Iudici M, Quartier P, Terrier B, Mouthon L, Guillevin L, Puéchal X.

Orphanet J Rare Dis. 2016 Oct 22;11(1):141. Review.

40.

Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial.

Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, Thoumie P, Cabane J, Chatelus E, Sibilia J, Roren A, Berezne A, Baron G, Porcher R, Guillevin L, Ravaud P, Poiraudeau S.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):1050-1059. doi: 10.1002/acr.23098. Epub 2017 Jun 7.

41.

Changes over Time and Responsiveness of the Cochin Hand Function Scale and Mouth Handicap in Systemic Sclerosis Scale in Patients with Systemic Sclerosis: A Prospective Observational Study.

Nguyen C, Bérezné A, Mestre-Stanislas C, Lefèvre-Colau MM, Rannou F, Guillevin L, Mouthon L, Poiraudeau S.

Am J Phys Med Rehabil. 2016 Dec;95(12):e189-e197.

PMID:
27584140
42.

Blood transfusion in 2016-Towards a "Nouvelle Vague" therapy?

Garraud O, Guillevin L.

Presse Med. 2016 Jul-Aug;45(7-8 Pt 2):e243-5. doi: 10.1016/j.lpm.2016.06.015. Epub 2016 Jul 29. No abstract available.

PMID:
27476780
43.

Tumor-Like Presentation of Primary Angiitis of the Central Nervous System.

de Boysson H, Boulouis G, Dequatre N, Godard S, Néel A, Arquizan C, Detante O, Bloch-Queyrat C, Zuber M, Touzé E, Bienvenu B, Aouba A, Guillevin L, Naggara O, Pagnoux C; French Vasculitis Study Group.

Stroke. 2016 Sep;47(9):2401-4. doi: 10.1161/STROKEAHA.116.013917. Epub 2016 Jul 28.

44.

[Congestive heart failure: Treatment with ultrafiltration].

Taron-Brocard C, Looten V, Fahlgren B, Charpentier E, Guillevin L, Barna A.

Ann Cardiol Angeiol (Paris). 2016 Sep;65(4):240-4. doi: 10.1016/j.ancard.2016.04.028. Epub 2016 Jun 22. Review. French.

PMID:
27344095
45.

Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.

Rossi B, Blanche P, Roussel-Robert V, Berezné A, Combe S, Coppo P, Guillevin L, Le Jeunne C, Mouthon L, Ounnoughene N, Stieltjes N, Groh M.

Haemophilia. 2016 Jul;22(4):e338-41. doi: 10.1111/hae.12973. Epub 2016 Jun 22. No abstract available.

PMID:
27329210
46.

Innovations in autoimmune diseases.

Guillevin L.

Presse Med. 2016 Jun;45(6 Pt 2):e157-8. doi: 10.1016/j.lpm.2016.05.001. Epub 2016 May 30. No abstract available.

PMID:
27256974
47.

New therapeutic approaches for ANCA-associated vasculitides.

Chaigne B, Guillevin L.

Presse Med. 2016 Jun;45(6 Pt 2):e171-8. doi: 10.1016/j.lpm.2016.05.003. Epub 2016 May 30. Review.

PMID:
27256972
48.

Do vaccinations affect the clinical course of systemic necrotising vasculitis? A prospective observational web-based study.

Kernéis S, Turbelin C, Pagnoux C, Launay O, Mahr AD, Guillevin L, Boëlle PY, Hanslik T.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S89-92. Epub 2016 May 19.

PMID:
27214210
49.

Treating giant-cell arteritis: is IL-6 the cytokine to target?

Guillevin L, Régent A.

Lancet. 2016 May 7;387(10031):1882-3. doi: 10.1016/S0140-6736(16)30183-0. No abstract available.

PMID:
27203632
50.

Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis.

Lionaki S, Mavragani CP, Karras A, Liapis G, Somarakis G, Boletis JN, Drosos A, Tzioufas AG, Guillevin L, Moutsopoulos HM.

J Autoimmun. 2016 Aug;72:57-64. doi: 10.1016/j.jaut.2016.05.004. Epub 2016 May 15.

PMID:
27194577

Supplemental Content

Loading ...
Support Center